Publications:127
Gregory A Elder, MD
About Me
Language
English
Position
PROFESSOR | Psychiatry, PROFESSOR | Neurology
Research Topics
Aging, Alzheimer's Disease, Brain, Endothelial Cells, Neuro-degeneration/protection, Stem Cells
Multi-Disciplinary Training Areas
Neuroscience [NEU]
Education
BA, University of Illinois
Research
Research interests include Alzheimer's disease and related dementias, in particular how mutations in presenilin-1 cause familial Alzheimer's disease using transgenic mouse models. We also study the normal biological functions of the presenilin-1 gene using mouse models and cell culture.
Key words:
Alzheimer's disease
Presenilin-1
Familial Alzheimer's disease
Transgenic mice
Key words:
Alzheimer's disease
Presenilin-1
Familial Alzheimer's disease
Transgenic mice
Publications
Selected Publications
- Intramural hematomas and astrocytic infiltration precede perivascular inflammation in a rat model of repetitive low-level blast injury. Miguel A. Gama Sosa, Rita De Gasperi, Rachel H. Lind, Dylan Pryor, Danielle C. Vargas, Georgina S. Perez Garcia, Gissel M. Perez, Rania Abutarboush, Usmah Kawoos, Allison Sowa, Carolyn W. Zhu, William G.M. Janssen, Patrick R. Hof, Stephen T. Ahlers, Gregory A. Elder. Journal of Neuropathology and Experimental Neurology
- Minocycline partially reverses established PTSD-related behavioral traits in rats exposed to repetitive low-level blast injury. Georgina Pérez Garcia, Gissel M. Perez, Rita De Gasperi, Miguel A. Gama Sosa, Rania Abutarboush, Usmah Kawoos, Carolyn Zhu, Carlos A. Toro, Patrick R. Hof, Stephen T. Ahlers, Gregory A. Elder. Frontiers in Neurology
- Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure. Rita De Gasperi, Georgina Perez Garcia, Miguel A. Gama Sosa, Gissel M. Perez, Rania Abutarboush, Usmah Kawoos, Patrick R. Hof, Carolyn W. Zhu, Stephen T. Ahlers, Gregory A. Elder. Frontiers in Neurology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Elder has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.